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SUMMARY 
 Prodigiosin (Pg), which is particularly of interest because of anticancer and antimicrobial activities, can be 
produced through the PigC-catalyzed condensation reaction of 4-methoxy-2, 2’-bipyrrole-5-carboxyaldehyde 
(MBC) and 2-methyl-3-amylpyrrole (MAP). Therefore, the PigC protein plays an important role in prodigiosin 
biosynthetic pathway. However, studies related to PigC protein have not been carried out in Vietnam yet. In 
this work, the pigC gene was cloned and expressed in Escherichia coli DH10B and BL21 (DE3), respectively. 
Using PCR and universal primers, we amplified a fragment of 3 kb covering entire	coding region of the pigC 
gene from Serratia sp. strain M5. The pigC gene was inserted into pJET1.2 vector, and then transformed into 
E. coli DH10B. The sequence of a recombinant vector pJET1.2/pigC was evaluated by using whole colony 
PCR amplification. Sequence alignment results revealed that the obtained pigC gene possesses 71.5% and 
75.4% of nucleotide identity in comparison with two strains, Serratia 39006 and Serratia sp. AS9 published in 
GenBank with their respective accession numbers of AJ833001 and CP002773. The recombinant vector 
pJET1.2/pigC was used to reamplify pigC, and the acquired amplicon was inserted into pET22b vector at the 
site of HindIII and XhoI. The clone E. coli BL21 (DE3) containing recombinant vector pET22b/pigC was 
expressed in the auto-induced medium. The presence of PigC protein in the lysate was identified as a 100 kDa 
band through Western Blot analysis using anti his-tag antibody. Afterward, the PigC protein was purified by 
Ni-NTA column, and its expression level was quantified through SDS-PAGE analysis. The results of our study 
provide a potential material for producing prodigiosin from recombinant protein in Vietnam.  
Keywords: MAP, MBC, pigC, prodigiosin, Vietnam  
INTRODUCTION 
 Prodigiosin (Pg), a red pigment belonging to the 
prodiginine group, is a tripyrrolic secondary 
metabolite isolated from Serratia marcescens. 
Recently, prodigiosin and its related compounds 
have been particularly of interest because of their 
biological activities (Darshan, Manonmani 2015). 
The selective anti-cancer property of prodigiosin and 
its analogues were well-demonstrated on many 
cancer cell lines (Diaz-Ruiz et al., 2001; Montaner et 
al., 2000; Tomás et al., 2003) as well as in vivo tests 
(Wang et al., 2016; Yamamoto et al., 1999; Zhang et 
al., 2005). In addition, prodigiosin and its derivatives 
also have antiparasitic and antimicrobial activities 
(Rahul et al., 2015; Suryawanshi et al., 2017). In 
Vietnam, there were a few studies interested in S. 
marcescens and prodigiosin. Nguyen (2015) 
extracted and evaluated antibiotic of prodigiosin 
against Bacillus subtilis and Staphylococcus aureus 
from S. marcescens strain M10. The anti-insect 
property against Spodoptera litura of S. marcescens 
and prodigiosin was also detected (Nguyen, Nguyen, 
2015). However, the opportunistic human pathogen 
S. marcescens species is harmful to human health, 
making it unsuitable for drug production by 
fermentation process (Domröse et al., 2015; Liu et 
al., 2017). Therefore, genetic engineering could 
create promising strategy for Pg production. 
 A biosynthetic gene cluster consisting 14-15 genes 
was identified to be responsible for Pg production in 
Serratia (Harris et al., 2004). Among these, a 
membrane located enzyme named PigC, with an 
approximate molecular weight of mass 100 kDa, plays 
a crucial role in the final step to produce prodigiosin 
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(Chawrai et al., 2008; Harris et al., 2004; Williamson et 
al., 2005). This enzyme is involved in the enzyme-
based condensation reaction of 4-methoxy-2, 2’-
bipyrrole-5-carboxyaldehyde (MBC) with 2-methyl-3-
amylpyrrole (MAP). Previous reports indicated that 
recombinant PigC protein is capable of using a wide 
range of substrate to synthesize prodigiosin and its 
derivatives applied in pharmaceutical industry (Chawrai 
et al., 2012; Chawrai et al., 2008; Klein et al., 2017; 
You et al., 2018a; You et al., 2018b). In 2017, Liu and 
colleagues selected a mutant which could produce up to 
12 fold increase in prodigiosin production when 
compared to the wild-type strains (Liu et al., 2017). In 
addition, prodigiosin biosynthesis gene cluster of S. 
marcescens was successfully transformed into 
Pseudomonas putida, leading to produce recombinant 
prodigiosin with 94 mg/Liter (Domröse et al., 2015). 
Therefore, it paves the way for applying recombinant 
PigC protein in pharmaceutical manufacturing. 
However, studying on PigC has not yet been performed 
in Vietnam. The aim of this study was to clone and 
express the recombinant PigC protein in E. coli in order 
to provide a potential material for producing large-scale 
prodigiosin.  
MATERIALS AND METHODS 
Materials 
 Serratia sp. M5 strain was provided by Enzyme 
Biotechnology laboratory, Institute of Biotechnology 
(IBT), Vietnam Academy of Science and 
Technology (VAST). E. coli DH10B (Invitrogen) 
and E. coli BL21 (DE3) strains (Novagen) were used 
as cloning and expression hosts, respectively. Vector 
pJET1.2 was utilized as cloning one and pET22b 
(Novagen) as expression vector. E. coli and Serratia 
sp. strains were respectively grown in media 
containing 1% NaCl, 1% tryptone, 0.5% yeast 
extract (Merck, Germany) at 37°C and 30°C.  
Methods 
Primer design for amplification of pigC gene 
 Because of highly variable sequences of pigC 
among strains available in Genbank, complete 
sequences of Pg clusters from different strains 
available in Genbank were downloaded and aligned. 
The consensus sequences being 300 nucleotides away 
from the pigC gene were chosen to design primers. 
After cloning, the obtained sequence of the region 
covering the pigC gene was used to design expression 
primers. The primer sequences were listed in Table 1.  
Total DNA extraction and sequence amplification 
 Total DNA was extracted from S. macescence 
using GeneJET Genomic purification kit according 
to the manufacturer’s instruction. The pigC gene was 
amplified with pigC universal pair of primers (Table 
1) using the following program: 98oC for 30 sec; 40 
cycles of 98oC 10 sec, 58oC for 15 sec, 72oC for 1 
min 30 sec, and a final cycle of 72oC for 5 min.  
 The targeted band was purified via GeneJET gel 
extraction kit according to the vendor’s manual. This 
candidate sequence was then ligated into pJET1.2 
blunt vector and transformed into E. coli DH10B 
chemically competent cells as described before. 
Several colonies were selected for further 
examination using plasmid extraction and 
sequencing by pJET1.2 specific primers (Table 1).  
 PigC encoded gene was reamplified from 
colonies containing recombinant vector using the 
primers pigC_HindIII_F and pigC_XhoI_R (Table 
1). The amplified product was digested with HindIII 
and XhoI (ThermoFisher Scientific, USA) and 
ligated into the vector pET22b. The ligated product 
was transformed into E. coli DH10B strain 
(Sambrook et al., 2001). Some clones were further 
examined using PCR, plasmid extraction, enzyme 
digestion and sequencing by T7 primers (Table 1). 
Table 1. Primer pairs used in this study. 
Primer names Primer sequences 
PigC_universal_F 5’ TATTCAYTTCGCYAATCAGGACA 3’ 
PigC_universal_R 5’ AAATTCGGYCACKAYAMAGCC 3’ 
PigC_HindIII.F 5’ AAAAAAAAGCTTAATCCTACCCTGGTGGTTGA 3’ 
PigC_XhoI.R 5’ AAAAAACTCGAGGCCATCGGCACGTTCTC 3’ 
pJET1.2F 5’ CGACTCACTATAGGGAGAGCGGC 3’ 
pJET1.2R 5’ AAGAACATCGATTTTCCATGGCAG 3’ 
T7 Promoter 5’ TAATACGACTCACTATAGGG 3’ 
T7 Terminator 5’ GCTAGTTATTGCTCAGCGG 3’ 
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Expression of pigC in E. coli BL21 (DE3) and 
protein purification 
 The recombinant vector with the correct 
sequence was transformed into BL21 (DE3) and 
expressed using auto-induced medium. In brief, 
overnight culture was inoculated into auto-induced 
medium containing tryptone 10 g/l, yeast extract 5 
g/l, NaCl 5 g/l, KH2PO4 6.8 g/l, Na2HPO4 7.1 g/l, 
(NH4)2SO4 3.3g/l, MgSO4 2 mM, glucose 0.05%, 
glycerol 0.5%, and lactose 0.2% w/v). Firstly, the 
culture was incubated at 37oC/200 rpm for 3 hours. 
The temperature was then decreased to 16oC and the 
culture was incubated for 16 hours for protein 
expression. Afterwards, the bacteria were pelleted by 
centrifugation at 6,000 g for 10 min. The pellet was 
solubilized in phosphate buffered saline (PBS, pH 
7.4) plus 8M urea (Sigma-Aldrich, USA) and 
sonicated for 1 min to release proteins from lysate. 
Subsequently, the soluble extract was centrifuged at 
13,000 g for 30 min at 4oC and the supernatant was 
transferred to a new tube. 
 The solution containing the targeted protein was 
supplemented with lysis and column equilibration 
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazole and 8M urea) at a ratio of 1:1 and then 
incubated with HisPur™ Ni-NTA Resin (Thermo 
Fisher Scientific, USA) at 4oC. After 2 hours, the 
flow through was removed and the protein-bound 
resin in Ni-NTA column was washed thoroughly 
three times with wash buffer containing 50 mM 
NaH2PO4, 300 mM NaCl, 50 mM imidazole (Sigma-
Aldrich, USA) and 8M urea. The recombinant 
proteins were achieved by eluting with elution buffer 
including the same ingredients with wash buffer but 
high concentration of imidazole (500 mM) from the 
Ni-NTA column and stored at -20oC. The expression 
and purification level were quantified by SDS-PAGE 
and Western blot analyses. 
RESULTS AND DISCUSSION 
Cloning pigC region from Serratia sp. strain M5 
 Electrophoresis result showed a shaped band 
with approximately expected size of 3000 bps 
representing pigC region sequences (Figure 1A). 
After purification, this obtained band was inserted 
into pJET1.2 vector and transformed into E. coli 
DH10B strain. Five clones were randomly selected 
for plasmid extraction. Result indicated that two 
clones contained the recombinant pJET1.2/insert 
(Figure 1B). The clones were further confirmed the 
presence of the insert by PCR method using a pair of 
pJET1.2 primers (Table 1), and an obviously single 
band of around 3 kb corresponding to pigC was 
observed in these clones (Figure 1C). Additionally, 
Sanger sequencing these PCR products indicated that 
pigC region was successfully amplified and inserted 
into vector pJET1.2. 
 
   
A B C 
Figure 1. (A) Electrophoresis of pigC amplification. M: Marker 1 kb (ThermoFisher Scientific), 1: PCR product of pigC region; 
(B) Plasmid extraction. M: Marker 1kb (Thermo Fisher Scientific), 1, 2, 3, 4, 5: Plasmid extraction from colonies 1, 2, 3, 4, 5, 
respectively. The arrows indicate recombinant vectors selected for further experiments; (C) PCR amplification using pJET1.2 
specific primers. 3, 5: PCR products obtained from the respective recombinant plasmid number 3 and 5. 
 
 Sequence alignment indicated that the pigC 
sequence of Serratia sp. strain M5 isolated in 
Vietnam has over 98% identity at the nucleotide 
level when compared with pigC of other strain S. 
marcescens WW4 from GenBank. However, it 
should be noted that the difference of pigC gene 
between Serratia sp. M5 strain and the well-known 
strains S. marcescens 39006 as well as Serratia sp. 
AS9 was up to 25 – 30% (Table 2). Previous reports 
observed that the proportion of similarity between 
Serratia strain 39006 and S. marcescens Sma was 
75.6% (Harris et al., 2004). The author’s hypothesis 
was that Serratia 39006 strain was atypical S. 
marcescens strain with significant differences in 
genome characteristics. The similar reason could be 
used to explain the difference between pigC of M5 
strain and that of strains AS9, AS12 or AS13 of S. 
plymuthica (Neupane et al., 2012a; Neupane et al., 
2012b; Neupane et al., 2012c). In addition, pigC 
clusters like Sma strain were observed in 6 
pigmented strains belonging to S. marcescens (Harris 
et al., 2004).  
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PigC expression in E. coli BL21 (DE3) 
 Complete sequence of pigC was amplified from 
recombinant vector pJET1.2/pigC and inserted into 
vector pET22b. After cloning, the final product was 
transformed into DH10B as described above. The 
recombinant vector was further examined by Sanger 
sequencing. As a result, there was no stop mutation 
detected in this construction, and an amino acid 
substitution at the position K265R was revealed when 
aligned with the pigC of S. marcescens WW4 (Figure 
2). On the other hand, deduced amino acid sequence 
comparison showed some differences scattered 
throughout the protein sequence when compared to 
those of other strains Serratia sp. 39006 and AS9 
(Table 2). 
Table 2. Nucleotide (lower triangle) and amino acid (upper triangle) identification matrix of pigC from Serratia sp. M5 strain in 
comparison to reference database from GenBank. 
No Strain 1 2 3 4 5 6 7 8 9 10 11 12 13 14
1 HQ833702S.marcescens jx1 99.5% 99.5% 99.2% 98.9% 98.9% 99.2% 98.9% 79.1% 79.1% 79.1% 74.8% 99.7% 99.6%
2 CP005927 Serratia sp. FS14 99.5% 99.5% 99.2% 98.9% 98.9% 99.2% 98.9% 79.2% 79.2% 79.2% 75.1% 99.5% 99.4%
3 CP021984 S.marcescens S2I7 99.4% 99.6% 99.4% 99.2% 99.2% 99.2% 98.9% 79.3% 79.3% 79.3% 74.9% 99.7% 99.6%
4 CP013046 S.marcescens B3R3 99.3% 99.4% 99.5% 99.7% 99.1% 99.1% 98.8% 79.3% 79.3% 79.3% 75.0% 99.2% 99.1%
5 CP016032 S.marcescens U36365 99.2% 99.2% 99.4% 99.8% 98.8% 98.8% 98.6% 79.2% 79.2% 79.2% 75.0% 98.9% 98.8%
6 CP016948 Serratia sp. YD25 98.8% 98.8% 98.9% 98.9% 98.8% 99.1% 98.8% 79.1% 79.1% 79.1% 74.9% 98.9% 98.8%
7 AJ833002 S.marcescens 98.8% 98.8% 98.8% 98.8% 98.7% 98.6% 99.7% 79.4% 79.4% 79.4% 75.4% 99.2% 99.1%
8 CP018927 S.marcescens UMH8 98.8% 98.7% 98.8% 98.7% 98.6% 98.5% 99.7% 79.4% 79.4% 79.4% 75.3% 98.9% 98.8%
9 CP002775 Serratia sp. AS13 75.3% 75.3% 75.4% 75.3% 75.2% 75.1% 75.3% 75.2% 100.0% 100.0% 79.7% 79.1% 79.1%
10 CP002774 Serratia sp. AS12 75.3% 75.3% 75.4% 75.3% 75.2% 75.1% 75.3% 75.2% 100.0% 100.0% 79.7% 79.1% 79.1%
11 CP002773 S.plymuthica AS9 75.3% 75.3% 75.4% 75.3% 75.2% 75.1% 75.3% 75.2% 100.0% 100.0% 79.7% 79.1% 79.1%
12 AJ833001 Serratia 39006 71.6% 71.6% 71.5% 71.5% 71.5% 71.4% 71.4% 71.4% 76.7% 76.7% 76.7% 74.8% 74.8%
13 CP003959 S.marcescens WW4 99.5% 99.6% 99.8% 99.3% 99.2% 98.9% 98.9% 98.8% 75.3% 75.3% 75.3% 71.5% 99.8%
14 M5 99.6% 99.5% 99.7% 99.3% 99.2% 98.9% 98.9% 98.8% 75.3% 75.3% 75.3% 71.6% 99.8%  
 
70              
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  ATGAATCCTACCCTGGTGGTTGAACTTTCCGGCGATAAAACGCTGGAACCCCATCGCCTGGGCGGCAAAG  
              M  N  P  T  L  V  V  E  L  S  G  D  K  T  L  E  P  H  R  L  G  G  K  
      140         
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  CCCATTCGTTGAATCATTTGATTCAGGCGGGCTTGCCGGTGCCGCCGGCGTTTTGCATCACCGCGCAGGC  
             A  H  S  L  N  H  L  I  Q  A  G  L  P  V  P  P  A  F  C  I  T  A  Q  A  
      210       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  TTACCGGCAGTTTATCGAATTCGCCGTGCCGGGAGCGCTGCTCGACACGGGCGCGCCGGGCAACGTGCGC  
               Y  R  Q  F  I  E  F  A  V  P  G  A  L  L  D  T  G  A  P  G  N  V  R  
      280       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GATATGATTTTGAGCACCGCCATCCCCGCCCCGCTCGATCTGGCGATCCGTCACGCCTGCAAACAGTTGG  
              D  M  I  L  S  T  A  I  P  A  P  L  D  L  A  I  R  H  A  C  K  Q  L  
      350       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GCGACGGCGCCTCGCTCGCCGTGCGCTCTTCGGCGCTGGAAGAAGACGGCCTGACCCACTCTTTCGCCGG  
             G  D  G  A  S  L  A  V  R  S  S  A  L  E  E  D  G  L  T  H  S  F  A  G  
      420       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GCAATACGACACTTACCTGCACGTGCGCGGGGATGACGAGGTGGTGCGCAAGGTGCAATCCTGCTGGGCG  
               Q  Y  D  T  Y  L  H  V  R  G  D  D  E  V  V  R  K  V  Q  S  C  W  A  
      490       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  TCGCTCTGGGCGGAACGCGCCGCCCAGTATAGCCGGACATCGGCGGCGCAGAGCGATATCGCCGTCGTCT  
              S  L  W  A  E  R  A  A  Q  Y  S  R  T  S  A  A  Q  S  D  I  A  V  V  
      560       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  TGCAAATCATGGTGGATGCAGACGCCGCCGGCGTCATGTTTACCCAAGATCCGCTGACAGGCGATGCCAA  
             L  Q  I  M  V  D  A  D  A  A  G  V  M  F  T  Q  D  P  L  T  G  D  A  N  
      630       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
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Pet22b_pigC  CCACATCGTCATCGACAGCTGCTGGGGGCTGGGGGAAGGCGTGGTCTCCGGACAGGTCACCACCGACAGC  
               H  I  V  I  D  S  C  W  G  L  G  E  G  V  V  S  G  Q  V  T  T  D  S  
      700       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  TTCATTTTGGATAAGGCGAGCGGCGAGATCCGCGAGCGGCAAATTCGTCACAAACCGCACTATTGCCAAC  
              F  I  L  D  K  A  S  G  E  I  R  E  R  Q  I  R  H  K  P  H  Y  C  Q  
      770       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GCGATCCGCAGGGACGGGTCACGCTGCTGCAAACGCCTGAAGTCAGGCGAGACGCCCCCAGCCTAACCCC  
             R  D  P  Q  G  R  V  T  L  L  Q  T  P  E  V  R  R  D  A  P  S  L  T  P  
 
                     780       790       800       810       820       830       840       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GGAACAGCTGCAACAGCTTGCCAGGCTGGCCAGGCAAACGCGGATGATTTACGGCGCGGAACTGGATATC  
               E  Q  L  Q  Q  L  A  R  L  A  R  Q  T  R  M  I  Y  G  A  E  L  D  I  
                     850       860       870       880       890       900       910       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GAATGGGCGGTGAAAGACGATCGCGTGTGGCTCCTGCAGGCGCGGCCGATCACCACGCAGGCCAAACCGG  
              E  W  A  V  K  D  D  R  V  W  L  L  Q  A  R  P  I  T  T  Q  A  K  P  
                     920       930       940       950       960       970       980       
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  TTCAGATGCTTTACGCCAACCCGTGGGAAAGCGATCCGGCGATCAAGGAACGGGCCTTTTTCTCCCGAAT  
             V  Q  M  L  Y  A  N  P  W  E  S  D  P  A  I  K  E  R  A  F  F  S  R  M  
                     990       1000      1010      1020      1030      1040      1050      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GGACACCGGCGAGATCGTCACCGGCTTGATGACGCCGCTGGGGCTGTCGTTTTGCCAGTTCTACCAAAAG  
               D  T  G  E  I  V  T  G  L  M  T  P  L  G  L  S  F  C  Q  F  Y  Q  K  
     1120      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  CATATTCATGGCCCGGCGATCAAAACCATGGGGCTGGCGGATATCGGCGATTGGCAGATTTATATGGGGT  
              H  I  H  G  P  A  I  K  T  M  G  L  A  D  I  G  D  W  Q  I  Y  M  G  
     1190      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  ATTTGCAAGGCTACGTCTATCTGAATATCTCCGGATCGGCCTACATGCTCCGCCAATGCCCGCCCACCCG  
             Y  L  Q  G  Y  V  Y  L  N  I  S  G  S  A  Y  M  L  R  Q  C  P  P  T  R  
     1260      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  CGACGAAATGAAGTTCACGACCCGCTACGCCACCGCCGATATCGATTTCAGCGGGTACAAAAACCCCTAT  
               D  E  M  K  F  T  T  R  Y  A  T  A  D  I  D  F  S  G  Y  K  N  P  Y  
     1330      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GGCCCCGGCGTACAGGGATGGGCTTATCTCAAGAGCGCCTGGCATTGGCTGAAACAGCAGAGGCATAACC  
              G  P  G  V  Q  G  W  A  Y  L  K  S  A  W  H  W  L  K  Q  Q  R  H  N  
     1400      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  TGCGCAGCGCCGGCGCGACCGTCGATGCCATGATCGCCCTGCGCCAGCGCGAGACGCGCCGCTTTCTGGC  
             L  R  S  A  G  A  T  V  D  A  M  I  A  L  R  Q  R  E  T  R  R  F  L  A  
                     1410      1420      1430      1440      1450      1460      1470      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GCTGGATCTGACCACCATGACGCATCAGGAGCTGGAGCGGGAACTCAGCCGCATCGACGGTTACTTCCTC  
               L  D  L  T  T  M  T  H  Q  E  L  E  R  E  L  S  R  I  D  G  Y  F  L  
                     1480      1490      1500      1510      1520      1530      1540      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GACAGCTGCGCCGCCTATATGCCCTTCTTCCTTCAGTCGTTCGCGCTCTACGATGCGCTGGCGCTGACCT  
              D  S  C  A  A  Y  M  P  F  F  L  Q  S  F  A  L  Y  D  A  L  A  L  T  
     1610      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GCGAACGTTACCTCAAAGGCCGCGGCAACGGATTGCAAAATCGCATCAAGGCGTCGATGAACAACCTGCG  
             C  E  R  Y  L  K  G  R  G  N  G  L  Q  N  R  I  K  A  S  M  N  N  L  R  
     1680      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  CACCATCGAAGTCACGCTGGGCATTCTCAGCCTGGTGGAGACGGTCAATCGTCAACCGGCGTTGAAGGCC  
               T  I  E  V  T  L  G  I  L  S  L  V  E  T  V  N  R  Q  P  A  L  K  A  
     1750      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GTGTTCGAGCGACACAGCGCACAGGAACTGGTCACCGTCCTGCCCACCGATCCCGAATCGCGCGCCTTCT  
              V  F  E  R  H  S  A  Q  E  L  V  T  V  L  P  T  D  P  E  S  R  A  F  
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     1820      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GGCAAAGCGACTTCAGCGCCTTCCTGTTCGAGTTCGGCGCCCGTGGCCGCCAGGAGTTCGAATTGAGTCT  
             W  Q  S  D  F  S  A  F  L  F  E  F  G  A  R  G  R  Q  E  F  E  L  S  L  
     1890      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  TCCGCGCTGGAACGACGATCCCAGCTACCTGCTGCAAGTGATGAAAATGTATCTGCAACATCCGGTGGAT  
               P  R  W  N  D  D  P  S  Y  L  L  Q  V  M  K  M  Y  L  Q  H  P  V  D  
 
     1960      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  CTGCACACGAAACTGCGGGAAACAGAGCGGCTGCGCCATGAAGACAGCGCGACGCTGCTTAAAGCGATGC  
              L  H  T  K  L  R  E  T  E  R  L  R  H  E  D  S  A  T  L  L  K  A  M  
     2030      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  CCTGGTTTGGCCGGATGAAGCTGAAGTTCATCACCAAGCTGTATGGCGTGATGGCCGAACGCCGCGAAGC  
             P  W  F  G  R  M  K  L  K  F  I  T  K  L  Y  G  V  M  A  E  R  R  E  A  
     2100      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GACCCGGCCAACCTTCGTCACCGAAACCTGGTTCTACCGCCGCATCATGTTGGAAGTGCTGCGGCGCCTG  
               T  R  P  T  F  V  T  E  T  W  F  Y  R  R  I  M  L  E  V  L  R  R  L  
     2170      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GAGGCGCAAGGCCTGGTCAAACAGGCCGATCTGCCCTATGTGGACTTCGAGCGCTTCCGCGCGTTTATGG  
              E  A  Q  G  L  V  K  Q  A  D  L  P  Y  V  D  F  E  R  F  R  A  F  M  
     2240      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  CGGGGGAACTGTCGGCGCAGGAGGCGTTCGCCGCCGATCTGATCGAGCGCAATCGCCACCAGCATCTGCT  
             A  G  E  L  S  A  Q  E  A  F  A  A  D  L  I  E  R  N  R  H  Q  H  L  L  
     2310      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GAACCTGCATGCGGAAGAGCCGCCGATGGCGATCGTCGGGGGGTATCAGCCCAGGATGAAAGCCCCCACG  
               N  L  H  A  E  E  P  P  M  A  I  V  G  G  Y  Q  P  R  M  K  A  P  T  
     2380      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  GCGGAAAACGCCGCCGGCATGCTGTCCGGCCTGGCGGCCAGCCCCGGCAAAGTGGTGGCGAAGGCGCGCG  
              A  E  N  A  A  G  M  L  S  G  L  A  A  S  P  G  K  V  V  A  K  A  R  
     2450      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  TCATCACCGATCTGCTGGCGCAGGCCGGCGAGCTGCAGCCCAACGAAATCCTGGTGGCGCGCTTTACCGA  
             V  I  T  D  L  L  A  Q  A  G  E  L  Q  P  N  E  I  L  V  A  R  F  T  D  
     2520      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  CGCCAGCTGGACCCCGCTCTTCGCGCTGGCGGCGGGCATCGTCACCGATATCGGCTCCGCGCTGTCCCAC  
               A  S  W  T  P  L  F  A  L  A  A  G  I  V  T  D  I  G  S  A  L  S  H  
     2590      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  AGCTGCATCGTCGCACGCGAATTCGGCATCCCCGCGGCGGTCAATCTCAAGAACGCCACCCAGCTGATCA  
              S  C  I  V  A  R  E  F  G  I  P  A  A  V  N  L  K  N  A  T  Q  L  I  
                              2660      
             ....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
Pet22b_pigC  ACAGCGGCGACACCTTGATTCTCGACGGCGACAGCGGGACGGTCATTATTCAACGCGGAGAACGTGCCGA  
             N  S  G  D  T  L  I  L  D  G  D  S  G  T  V  I  I  Q  R  G  E  R  A  D  
             
             .... 
Pet22b_pigC  TGGC  
               G  
Figure 2. Nucleotide sequence and deduced amino acid sequence of pET22b/pigC. 
  
 Recombinant vector pET22b/pigC was initially 
expressed in E. coli BL21 (DE3) in LB medium 
supplemented 100 µg/ml ampicilline and 1 mM 
IPTG at 37oC/6 hours or at 16oC/16 hours. However, 
the expression of pigC under this condition was 
really weak (data not shown). Previous reports 
indicated that maximum production of PigC was 
achieved using optimized auto-induced medium 
(You et al., 2018b), which was therefore used for 
expressing the targeted pigC protein. As a result, a 
Journal of Biotechnology 16(4): 757-765, 2018 
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sharp band of approximately 100 kDa was observed 
in Western blot using anti his-tag antibody (Figure 
3A).  
 In order to purify the PigC protein for further 
study, the phase of recombinant PigC under 
expression conditions was investigated. Results 
indicated that recombinant PigC mostly accumulated 
in the pellet fraction (data not shown). Furthermore, 
it should be mentioned that PigC protein was 
demonstrated as a membrane binding protein in vivo 
and in vitro with full activity observed in pellets 
(Chawrai et al., 2012; You et al., 2018a). In these 
studies, therefore, a majority of recombinant PigC 
was in the insoluble fraction. In addition, enzymatic 
reaction indicated that enzyme activity was 
maintained in this fraction whereas no activity was 
identified in the supernatant. For all above the 
reasons, we further purified PigC protein under the 
denaturing condition using Ni-NTA resin. As 
expected, we achieved a purified	 precise band with 
the size corresponding to PigC protein (Figure 3B). 
This purified protein can be refolded and applied for 
examining the characteristics of recombinant PigC 
protein as well as producing prodigiosin. 
 
 
A 
 
B 
Figure 3. (A) Western Blot result of expression of recombinant PigC protein in E. coli. M: marker gangnam stain (Intron), 1: 
E. coli BL21 (DE3) strain containing vector pET22b, 2: E. coli BL21 (DE3) strain containing recombinant vector 
pET22b_LacP_pigC; (B) Purification of PigC protein. M: marker Gangnam stain (Intron), 1: Purified PigC. 
  
CONCLUSION 
 In the present study, the pigC sequence from 
Serratia sp. M5 isolated in Vietnam was successfully 
cloned into pJET1.2 vector. This gene, 2667 bps in 
length, encoded a protein of 888 amino acids. 
Sequence comparison indicated the obtained 
sequence of the pigC gene was highly similar to that 
of S. marcescens WW4, sharing over 98% of their 
DNA sequence. Meanwhile, it was 25 – 30% 
different from those of Serratia sp. 39006 and AS9 
strains. The pigC gene was then inserted into 
pET22b and expressed in E. coli BL21 (DE3) using 
auto-induced medium. The targeted PigC, being a 
100 kDa protein in SDS-PAGE as well as in Western 
blot analyses, was purified by Ni-NTA column. The 
prodigiosin production using the purified 
recombinant pigC is being examined in the further 
study. 
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TÁCH DÒNG VÀ BIỂU HIỆN GEN pigC TRONG ESCHERICHIA COLI  
 
Đỗ Minh Trung1, Đỗ Hải Quỳnh2, Trần Viết Tiến1, Nguyễn Duy Bắc1, Đỗ Thị Tuyên3, Nguyễn Thùy 
Dương2 
1Học viện Quân y 
2Viện Nghiên cứu hệ gen, Viện Hàn lâm Khoa học và Công nghệ Việt Nam 
3Viện Công nghệ sinh học, Viện Hàn lâm Khoa học và Công nghệ Việt Nam 
TÓM TẮT 
 Prodigiosin (Pg) có hoạt tính kháng ung thư hoặc kháng vi sinh vật được tổng hợp từ phản ứng ngưng kết 
4-methoxy-2, 2’-bipyrrole-5-carboxyaldehyde (MBC) và 2-methyl-3-amylpyrrole (MAP) dưới sự xúc tác của 
enzyme PigC. Mặc dù PigC đóng vai trò quan trọng trong quá trình tổng hợp prodigiosin tuy nhiên chưa có 
nghiên cứu nào về protein này được thực hiện ở Việt Nam. Trong nghiên cứu này, chúng tôi đã tách dòng và 
biểu hiện protein PigC ở Escherichia coli. Sử dụng cặp mồi chung cho vùng gen pigC, đoạn gen khoảng 3kb 
chứa pigC được khuếch đại thành công từ chủng Serratia sp. chủng M5. Kết quả so sánh trình tự cho thấy, 
trình tự pigC có kích thước 2667 bp của chủng M5 phân lập tại Việt Nam tương đồng 98% với trình tự của các 
chủng S. marcescens khác, tuy nhiên khác biệt tới 30% khi so với chủng S. marcescens 39006 và AS9 với mã 
số tương ứng	AJ833001 và CP002773. Trình tự gen mã hoá protein PigC với kích thước 2664 bp sau khi được 
nhân lên sử dụng cặp mồi có chứa vị trí nhận biết enzyme cắt HindIII và XhoI được đưa vào vector pET22b tạo 
thành vector tái tổ hợp có gắn đuôi His và biểu hiện ở E. coli sử dụng môi trường tự cảm ứng. Kết quả điện di 
cho thấy protein PigC đã được biểu hiện thành công với kích thước ~100 kDa và được kiểm tra bằng kĩ thuật 
Western Blot sử dụng kháng thể kháng 6 histidine. Kết quả này tạo nguồn nguyên liệu khởi đầu cho việc 
nghiên cứu tạo prodigiosin từ protein tái tổ hợp ở Việt Nam. 
Từ khoá: MAP, MBC, pigC, prodigiosin, Việt Nam 
 
 
